Black Diamond Therapeutics shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Kennedy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $493k | 130k | 3.79 |
| 2025-06-30 | $163k | 66k | 2.48 |
| 2025-03-31 | $99k | 64k | 1.55 |
| 2024-12-31 | $928k | 434k | 2.14 |
| 2024-09-30 | $2.9M | 657k | 4.35 |
| 2024-06-30 | $3.3M | 703k | 4.66 |
| 2024-03-31 | $3.6M | 717k | 5.07 |
| 2023-12-31 | $2.1M | 741k | 2.81 |
| 2023-09-30 | $2.2M | 750k | 2.87 |
| 2023-06-30 | $3.8M | 751k | 5.05 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management